Insights from the 9th Pricing & Revenue Management Summit in Berlin, where Stratence Partners shared perspectives on how organizations are integrating strategy, pricing economics and sales execution into structured Commercial Transformation frameworks.

Greg Varner joins Stratence Partners as Senior Vice President, bringing 25+ years of global leadership experience in commercial transformation, pricing strategy and profitable growth.

A moment captured at EPA 2026 in Amsterdam reflects the importance of teamwork across Andersen and Stratence Partners leadership, bringing together expertise from Tax, Commercial Transformation and Healthcare industry strategy.

At EPA 2026, Stratence Partners will lead two executive sessions in the Pricing and AI tracks and host business-focused Poster Sessions on Commercial Transformation, AI Powered. Meet us at Booth 300A.

Ahead of EPA 2026, Stratence Partners is hosting a closed-door VIP Dinner for selected VP and C-level executives in Pricing, Market Access, Commercial and Finance governance.

EPA 2026: From Attendance to Impact The World Evidence, Pricing & Access Congress remains Europe’s most relevant gathering for senior leaders in pricing, market access, HEOR, and commercial strategy. But attendance alone does not create value. Impact comes from addressing structural weaknesses that silently erode EBIT year after year. As a global firm specialized in Commercial Transformation, AI Powered, Stratence Partners returns to EPA 2026 with two focused executive sessio

In Medical Devices, margin erosion rarely comes from innovation. It comes from fragmented commercial governance. Stratence Partners explains how Commercial Transformation, AI Powered, restores structural control and delivers measurable EBIT impact within year one.

In Oil & Gas, margin erosion is rarely caused by strategy. It is caused by weak execution, fragmented pricing governance and disconnected commercial decisions.

At EPA 2026, Stratence Partners will lead two executive sessions on Gross-to-Net discipline and AI-driven commercial transformation — focused on execution, governance and measurable impact.

Meet Stratence Partners in 2026 | Commercial Transformation & Pricing Events

Commercial performance does not come from isolated initiatives. It emerges from how Strategy, Pricing and Commercial Execution operate together as an integrated decision system.

Stratence Partners welcomes David Whitaker as Senior Vice President, Chemical Industry. With 40+ years of global experience, David strengthens Stratence’s leadership in commercial transformation for chemical and fragrance organizations.

Join Stratence Partners as Vice President Partner to lead Strategy & Digital Transformation in Europe. Drive innovation & growth.

Stratence Partners returns to EPA 2026 with two sessions that go beyond the buzzwords. Discover what we’ll be addressing — and why it matters.

How leading chemical companies are transforming volatility into commercial advantage through pricing excellence, governance and AI-enabled execution.

Meet Stratence Partners in 2026 across 10 key global events where pricing, commercial transformation and AI-driven execution take center stage. Discover where strategy turns into measurable impact.

In an environment of structural volatility and margin pressure, Commercial Excellence — accelerated by AI — is becoming the primary driver of profitability and valuation. This White Paper explores how leading organizations translate strategy into disciplined execution.

Join Stratence Partners as Vice President Partner to lead Strategy & Digital Transformation in Europe. Drive innovation & growth.

Stratence Partners will deliver two focused sessions at EPA 2026 addressing Gross-to-Net best practices and AI-driven commercial transformation. Join us March 3rd in Amsterdam.

Pharma transformations fail when operating models don’t evolve. Learn how Stratence Partners helps organizations embed change through governance, processes, and capability building.